Stay updated on Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedNew navigation/help links were added: Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study. The label Intervention / Treatment was reformatted to Intervention/Treatment, and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check21 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating an updated version of the page.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a newer version of the page metadata. This appears to be a minor update to the page instead of a substantive change to the study details.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now shows Revision: v3.5.3 instead of v3.5.2, indicating a small internal update; no study information or displayed content has been altered.SummaryDifference0.1%

- Check71 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.